Tell Congress to Urge FDA to Take Action on Improperly Tested Hepatitis B Vaccines
Attorneys for Informed Consent Action Network (ICAN) have filed a petition with the FDA demanding that the licensure for Hepatitis B vaccines be revoked or suspended until legally required safety is proven in a “properly designed clinical trial of sufficient duration.” In the clinical trials of the two Hepatitis B vaccines available for use in the U.S., Engerix-B and Recombivax HB, subjects were followed up for four days and five days respectively. According to the FDA, clinical trials typically take between one and four years to complete. Children’s Health Defense suggests the following letter be sent to your lawmakers to urge them to contact the FDA in support of ICAN’s petition to the agency.
Send the letter today to your state and federal representatives using our click-to-action system by filling out the form.
The post Tell Congress to Urge FDA to Take Action on Improperly Tested Hepatitis B Vaccines appeared first on Children's Health Defense.
© 11 Sep 2020 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
